文献速递技术与安全外周血管腹部US

24 个中心 463434 次检查中静脉注射六氟化硫微泡后的安全性发现

Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463,434 examinations at 24 centers.
PubMed 文献 · Eur Radiol · 2022-10-07

该回顾性评估分析了 2006 年 1 月至 2019 年 4 月 24 个中心因常规超声造影接受静脉注射六氟化硫微泡的患者,共 463434 次检查。不良事件频率为 0.034%,其中非严重事件 153 次(0.033%)、严重事件 4 次(0.001%);91% 的不良事件发生在给药后 30 分钟内。作者结论认为六氟化硫微泡不良事件频率很低、严重反应罕见,适合常规超声造影应用。

要点

  • 六氟化硫微泡总体不良事件频率为 0.034%(157/463434),严重事件仅 0.001%。
  • 非严重不良事件中轻度 0.014%、中度 0.015%、重度 0.004%。
  • 血管疾病超声造影的不良事件频率最高(0.092%),肝脏检查为 0.026%。

核心结论

  • 六氟化硫微泡的不良事件频率很低,严重反应罕见,证实其适合常规超声造影应用。

研究设计与样本

  • 回顾性评估 2006 年 1 月至 2019 年 4 月 24 个中心所有因超声造影接受静脉注射六氟化硫微泡的患者,共 463434 次检查。
  • 记录患者人口学资料、检查类型和给药剂量,使用特定不良事件记录工具,将不良事件分为严重和非严重,非严重按 ACR 标准分为轻度、中度、重度。
  • 采用卡方检验比较患者亚组间不良事件频率。

诊断标准与关键数值

  • 总体不良事件频率为 0.034%(157/463434),其中非严重 153 次(0.033%)、严重 4 次(0.001%)。
  • 非严重不良事件中,轻度 66 次(0.014%)、中度 70 次(0.015%)、重度 17 次(0.004%)。
  • 肝脏是最常见检查部位,不良事件频率为 0.026%;血管疾病患者超声造影的不良事件频率最高(0.092%)。
  • 男女性别在非严重不良事件总数或严重程度上无显著差异(卡方=2.497,p=0.287)。
  • 91% 的不良事件发生在六氟化硫微泡给药后 30 分钟内。

临床应用与阅片要点

  • 作者结论认为六氟化硫微泡适合常规超声造影应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to evaluate the safety of the ultrasound contrast agent sulfur hexafluoride microbubbles in a large group of patients referred for routine contrast-enhanced ultrasound (CEUS).

METHODS: A retrospective assessment was made of all patients that received sulfur hexafluoride microbubbles intravenously for CEUS at 24 centers between January 2006 and April 2019. Patient demographic details, examination type, and the dose of sulfur hexafluoride microbubbles administered were recorded with specific adverse events (AEs) documentation tools at each center. All AEs were recorded as serious or non-serious. Non-serious AEs were classified by intensity as mild, moderate, or severe according to ACR criteria. The frequencies of AEs across patient subgroups were compared using the chi-square test.

RESULTS: A total of 463,434 examinations were evaluated. Overall, 157 AEs (153 [0.033%] non-serious; 4 [0.001%] serious) were reported after sulfur hexafluoride microbubbles administration, giving an AE frequency of 0.034% (157/463,434). Among the non-serious AEs, 66 (0.014%) were mild, 70 (0.015%) moderate, and 17 (0.004%) severe in intensity. The liver was the most common examination site, presenting an AE frequency of 0.026%. The highest AE frequency (0.092%) was for patients undergoing CEUS for vascular disease. There were no significant gender differences in either the total number or the severity of non-serious AEs (chi-square = 2.497, p = 0.287). The onset of AEs occurred within 30 min of sulfur hexafluoride microbubbles administration in 91% of cases.

CONCLUSION: The frequency of AEs to sulfur hexafluoride microbubbles is very low and severe reactions are rare, confirming that sulfur hexafluoride microbubbles are appropriate for routine CEUS applications.

KEY POINT: • The frequency of AEs to sulfur hexafluoride microbubbles is very low and severe reactions are rare.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Shang Y, Xie X, Luo Y, et al. Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463,434 examinations at 24 centers. Eur Radiol. 2022. PMID: 36205769. doi:10.1007/s00330-022-09108-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。